OR WAIT null SECS
December 27, 2023
Article
The progression toward more targeted, disease-modifying options for the historically difficult rheumatic disease made more headway in 2023.
December 26, 2023
Video
Stacie Bell, PhD, emphasizes the importance of collaborative or multidisciplinary care in patients with SLE.
December 24, 2023
Stacie Bell, PhD, highlights the lasting effects of childhood adversities in patients with pediatric lupus.
December 22, 2023
Stacie Bell, PhD, discusses the disagreement between adolescents and parents regarding how lupus impacts daily life.
Data from the phase 3 TULIP long-term extension trial support the favorable benefit-risk profile of anifrolumab-fnia demonstrated in previous trials.
December 21, 2023
Results provide the first clinical evidence to suggest that afimetoran may offer a benefit to patients with cutaneous lupus erythematosus.
December 20, 2023
Throughout 2023, interest in the application of CAR-T and other cell therapies to autoimmune disease skyrocketed, with a multitude of clinical trials being initiated by various companies.
December 14, 2023
Expert rheumatologists discuss current treatment options for lupus nephritis and emerging therapies with newer mechanisms of action.
December 06, 2023
Podcast
November 15, 2023
This new late-breaking data presented at ACR 2023 was the first clinical evidence indicating efficacy of afimetoran for those with CLE.